We are live on
!
Find out more
SC
Stralem & Co Portfolio holdings
AUM
$157M
1-Year Est. Return
4.29%
This Fund
S&P 500
This Quarter
Est. Return
+0.22%
1 Year Est. Return
+4.29%
3 Year Est. Return
+25.48%
5 Year Est. Return
+55.56%
10 Year Est. Return
–
AUM
$1.79B
AUM Growth
-$362M
(-17%)
Cap. Flow
-$354M
Cap. Flow
% of AUM
-19.74%
Top 10 Holdings %
Top 10 Hldgs %
32.65%
Holding
57
New
5
Increased
2
Reduced
40
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson Controls International
JCI
|
+$56.2M |
| 2 |
CVS Health
CVS
|
+$54.2M |
| 3 |
UnitedHealth
UNH
|
+$53.9M |
| 4 |
Lowe's Companies
LOW
|
+$53M |
| 5 |
Johnson & Johnson
JNJ
|
+$36.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$88M |
| 2 |
Eaton
ETN
|
+$73.6M |
| 3 |
Visa
V
|
+$36.3M |
| 4 |
Walt Disney
DIS
|
+$33.5M |
| 5 |
Starbucks
SBUX
|
+$33.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.93% |
| 2 | Industrials | 12.29% |
| 3 | Energy | 12.26% |
| 4 | Communication Services | 11.55% |
| 5 | Utilities | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
EOG Resources
EOG
$75.1B
| $44.8M | 2.5% |
488,600
-62,379
| -11% | -$5.64M |
|
27
Qualcomm
QCOM
$171B
| $43.3M | 2.42% |
624,733
-73,331
| -11% | -$5.17M |
|
28
ExxonMobil
XOM
$657B
| $42.6M | 2.38% |
500,942
-58,941
| -11% | -$5.23M |
|
29
Chevron
CVX
$386B
| $42.2M | 2.36% |
401,923
-53,135
| -12% | -$5.67M |
|
30
Abbott
ABT
$192B
| $38.8M | 2.17% |
838,104
-460,391
| -35% | -$21.1M |
|
31
APA Corp
APA
$14B
| $38.8M | 2.17% |
643,150
-65,741
| -9% | -$4.14M |
|
32
Thermo Fisher Scientific
TMO
$223B
| $38.6M | 2.16% |
287,450
-153,230
| -35% | -$19.8M |
|
|
CELG
33
DELISTED
Celgene Corp
CELG
| $38.4M | 2.14% |
333,110
-190,883
| -36% | -$22.8M |
|
34
Amgen
AMGN
$225B
| $38.1M | 2.13% |
238,130
-125,791
| -35% | -$19.8M |
|
|
35
Johnson & Johnson
JNJ
$629B
| $35.9M | 2.01% |
+356,900
| New | +$36.3M |
|
|
TE
36
DELISTED
TECO ENERGY INC
TE
| $5.44M | 0.3% |
280,200
-29,600
| -10% | -$598K |
|
37
Mondelez International
MDLZ
$79.4B
| $4.86M | 0.27% |
134,750
-44,650
| -25% | -$1.61M |
|
38
Automatic Data Processing
ADP
$107B
| $1.96M | 0.11% |
22,850
-9,750
| -30% | -$840K |
|
39
Bristol-Myers Squibb
BMY
$130B
| $1.86M | 0.1% |
28,800
-700
| -2% | -$43.8K |
|
40
FirstEnergy
FE
$27.2B
| $1.74M | 0.1% |
49,600
-10,700
| -18% | -$400K |
|
41
Union Pacific
UNP
$174B
| $1.35M | 0.08% |
12,500
-5,900
| -32% | -$692K |
|
42
Agilent Technologies
A
$41.9B
| $1.23M | 0.07% |
29,500
-5,550
| -16% | -$225K |
|
43
Colgate-Palmolive
CL
$73.6B
| $1.19M | 0.07% |
17,100
-300
| -2% | -$20.7K |
|
44
International Flavors & Fragrances
IFF
$21.4B
| $1.13M | 0.06% |
+9,600
| New | +$1.08M |
|
45
Zimmer Biomet
ZBH
$18.7B
| $1.1M | 0.06% |
9,631
+7,056
| +274% | +$805K |
|
46
Berkshire Hathaway Class B
BRK.B
$1.09T
| $1.08M | 0.06% |
7,500
| – | – |
|
47
Gilead Sciences
GILD
$168B
| $824K | 0.05% |
8,400
-2,000
| -19% | -$203K |
|
48
PepsiCo
PEP
$189B
| $698K | 0.04% |
7,300
| – | – |
|
49
Procter & Gamble
PG
$335B
| $619K | 0.03% |
7,550
| – | – |
|
|
KRFT
50
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $579K | 0.03% |
6,650
-1,750
| -21% | -$116K |
|
Similar funds
LI
BC
JT
SCM
HF
SMFS
CCM
CCM
Stralem & Co's Q1 2015 Portfolio in Review
As of Q1 2015, Stralem & Co held 57 positions worth $1.79B, down 17% from $2.15B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Stralem & Co withdrew a net $354M in Q1 2015, closing 3 positions and reducing 40 holdings. Its most notable exit was Du Pont De Nemours E I, an estimated $88M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 21% a quarter earlier, followed by Industrials and Energy.
Against the trend, Stralem & Co opened a new position in Johnson Controls International worth $58.4M.
- Stralem & Co's largest Q1 2015 buy was Johnson Controls International: 1,106,415 shares worth $58.4M.
- Stralem & Co added most to UnitedHealth in Q1 2015, an estimated $53.9M increase.
- Stralem & Co's biggest Q1 2015 reduction was Visa, cutting an estimated $36.3M.
- Stralem & Co fully exited Du Pont De Nemours E I in Q1 2015, selling an estimated $88M.
- Stralem & Co's ten largest holdings make up 33% of its $1.79B portfolio in Q1 2015.
- Stralem & Co opened 5 new positions and closed 3 in Q1 2015.
- Stralem & Co's portfolio value fell 17% quarter-over-quarter to $1.79B.
Based on Stralem & Co's 13F filing for Q1 2015, filed 16 Apr 2015.